Literature DB >> 16287869

Multisite M-phase phosphorylation of Xenopus Wee1A.

Sun Young Kim1, Eun Joo Song, Kong-Joo Lee, James E Ferrell.   

Abstract

The Cdk1 inhibitor Wee1 is inactivated during mitotic entry by proteolysis, translational regulation, and transcriptional regulation. Wee1 is also regulated by posttranslational modifications, and here we have identified five phosphorylation sites in the N-terminal domain of embryonic Xenopus Wee1A through a combination of mutagenesis studies and matrix-assisted laser desorption ionization-time of flight mass spectrometry. All five sites conform to the Ser-Pro/Thr-Pro consensus for proline-directed kinases like Cdks. Three of the sites (Ser 38, Thr 53, and Ser 62) are required for the mitotic gel shift, and at least two of these sites (Ser 38 and Thr 53) regulate the proteolysis of Wee1A during interphase. The other two sites (Thr 104 and Thr 150) are primarily responsible for the mitotic inactivation of Wee1A. Alanine mutants of Thr 150 or Thr 104 had an increased capacity to inhibit mitotic entry in cyclin B-treated interphase extracts, and Thr 150 was found to be transiently phosphorylated just prior to nuclear envelope breakdown in cycling egg extracts. These findings establish the phosphorylation-dependent direct inactivation of Wee1A as a critical mechanism for the promotion of M-phase entry. These results also show that multisite phosphorylation cooperatively inactivates Wee1A and cooperatively promotes Wee1A proteolysis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16287869      PMCID: PMC1291245          DOI: 10.1128/MCB.25.23.10580-10590.2005

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  46 in total

1.  The temporal control of Wee1 mRNA translation during Xenopus oocyte maturation is regulated by cytoplasmic polyadenylation elements within the 3'-untranslated region.

Authors:  A Charlesworth; J Welk; A M MacNicol
Journal:  Dev Biol       Date:  2000-11-15       Impact factor: 3.582

2.  Genetic control of cell size at cell division in yeast.

Authors:  P Nurse
Journal:  Nature       Date:  1975-08-14       Impact factor: 49.962

3.  Bistability in cell signaling: How to make continuous processes discontinuous, and reversible processes irreversible.

Authors:  James E. Ferrell; Wen Xiong
Journal:  Chaos       Date:  2001-03       Impact factor: 3.642

4.  14-3-3 binding regulates catalytic activity of human Wee1 kinase.

Authors:  C J Rothblum-Oviatt; C E Ryan; H Piwnica-Worms
Journal:  Cell Growth Differ       Date:  2001-12

Review 5.  Regulation of Cdc2 activity by phosphorylation at T14/Y15.

Authors:  L D Berry; K L Gould
Journal:  Prog Cell Cycle Res       Date:  1996

6.  Negative regulation of mitosis by wee1+, a gene encoding a protein kinase homolog.

Authors:  P Russell; P Nurse
Journal:  Cell       Date:  1987-05-22       Impact factor: 41.582

7.  M-phase kinases induce phospho-dependent ubiquitination of somatic Wee1 by SCFbeta-TrCP.

Authors:  Nobumoto Watanabe; Harumi Arai; Yoshifumi Nishihara; Makoto Taniguchi; Naoko Watanabe; Tony Hunter; Hiroyuki Osada
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-22       Impact factor: 11.205

Review 8.  Cdc25A phosphatase: combinatorial phosphorylation, ubiquitylation and proteolysis.

Authors:  Luca Busino; Massimo Chiesa; Giulio F Draetta; Maddalena Donzelli
Journal:  Oncogene       Date:  2004-03-15       Impact factor: 9.867

9.  Numerical analysis of a comprehensive model of M-phase control in Xenopus oocyte extracts and intact embryos.

Authors:  B Novak; J J Tyson
Journal:  J Cell Sci       Date:  1993-12       Impact factor: 5.285

10.  Human Wee1 kinase inhibits cell division by phosphorylating p34cdc2 exclusively on Tyr15.

Authors:  C H McGowan; P Russell
Journal:  EMBO J       Date:  1993-01       Impact factor: 11.598

View more
  27 in total

Review 1.  Morphogenesis and the cell cycle.

Authors:  Audrey S Howell; Daniel J Lew
Journal:  Genetics       Date:  2012-01       Impact factor: 4.562

2.  Nonessential sites improve phosphorylation switch.

Authors:  Liming Wang; Qing Nie; German Enciso
Journal:  Biophys J       Date:  2010-09-22       Impact factor: 4.033

3.  The Prozone Effect Accounts for the Paradoxical Function of the Cdk-Binding Protein Suc1/Cks.

Authors:  Sang Hoon Ha; Sun Young Kim; James E Ferrell
Journal:  Cell Rep       Date:  2016-02-04       Impact factor: 9.423

Review 4.  Ubiquitin and SUMO systems in the regulation of mitotic checkpoints.

Authors:  Gustavo J Gutierrez; Ze'ev Ronai
Journal:  Trends Biochem Sci       Date:  2006-05-02       Impact factor: 13.807

5.  Activation domain-dependent degradation of somatic Wee1 kinase.

Authors:  Laura Owens; Scott Simanski; Christopher Squire; Anthony Smith; Jeff Cartzendafner; Valerie Cavett; Jennifer Caldwell Busby; Trey Sato; Nagi G Ayad
Journal:  J Biol Chem       Date:  2009-12-28       Impact factor: 5.157

6.  A bifunctional regulatory element in human somatic Wee1 mediates cyclin A/Cdk2 binding and Crm1-dependent nuclear export.

Authors:  Changqing Li; Mark Andrake; Roland Dunbrack; Greg H Enders
Journal:  Mol Cell Biol       Date:  2010-01       Impact factor: 4.272

7.  Quantitative reconstitution of mitotic CDK1 activation in somatic cell extracts.

Authors:  Richard W Deibler; Marc W Kirschner
Journal:  Mol Cell       Date:  2010-03-26       Impact factor: 17.970

8.  Human immunodeficiency virus type 1 Vpr binds to the N lobe of the Wee1 kinase domain and enhances kinase activity for CDC2.

Authors:  Masakazu Kamata; Nobumoto Watanabe; Yoshiko Nagaoka; Irvin S Y Chen
Journal:  J Virol       Date:  2008-04-02       Impact factor: 5.103

9.  Gauchos and ochos: a Wee1-Cdk tango regulating mitotic entry.

Authors:  Greg H Enders
Journal:  Cell Div       Date:  2010-05-13       Impact factor: 5.130

10.  Wee1B, Myt1, and Cdc25 function in distinct compartments of the mouse oocyte to control meiotic resumption.

Authors:  Jeong Su Oh; Seung Jin Han; Marco Conti
Journal:  J Cell Biol       Date:  2010-01-18       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.